Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report
Katrine Fladeland Iversen, Paw Christian Holdgaard, Birgitte Preiss, et al.
Haematologica (2019) Vol. 104, Iss. 9, pp. e432-e433
Open Access | Times Cited: 15

Showing 15 citing articles:

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30
Immunotherapy for Refractory Autoimmune Encephalitis
Jia‐Wei Yang, Xueyan Liu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature
Ramona Meier-Lienhard, Cosima Suter, Thomas Pabst, et al.
Schweizerische medizinische Wochenschrift (2025) Vol. 155, Iss. 1, pp. 3885-3885
Open Access
New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm
Xiang Zhang, Jiewen Sun, Min Yang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102928-102928
Closed Access | Times Cited: 19
CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123
Xiaoyi Hu, Asiri Ediriwickrema, Atif Saleem, et al.
Leukemia Research (2024) Vol. 139, pp. 107479-107479
Closed Access | Times Cited: 2
Evolving Role of Daratumumab: From Backbencher to Frontline Agent
Ankur Jain, Karthik Ramasamy
Clinical Lymphoma Myeloma & Leukemia (2020) Vol. 20, Iss. 9, pp. 572-587
Closed Access | Times Cited: 17
CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm
Elodie Bôle‐Richard, Naveen Pemmaraju, Blandine Caël, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2287-2287
Open Access | Times Cited: 9
Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Minas P. Economides, David A. Rizzieri, Naveen Pemmaraju
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 6, pp. 515-522
Closed Access | Times Cited: 13
Lymphocytes in autoimmune encephalitis: Pathogenesis and therapeutic target
Jiaojiao Chen, Mengting Qin, Xuying Xiang, et al.
Neurobiology of Disease (2024) Vol. 200, pp. 106632-106632
Open Access | Times Cited: 1
Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) – a new perspective
Sumeet Mirgh, Archana Sharma, Bhaarat Folbs, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 12, pp. 3039-3042
Closed Access | Times Cited: 10
Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm
Yumeng Zhang, Lubomir Sokol
Cancer Management and Research (2022) Vol. Volume 14, pp. 2107-2117
Open Access | Times Cited: 7
<p>Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation</p>
Yili Jiang, Qing Li, Ting Yuan, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 3425-3430
Open Access | Times Cited: 8
Blastic Plasmacytoid Dendritic Cell Neoplasm
Ayah K. Ali, Mark A. Russell, Kamran Mirza
Advances in Molecular Pathology (2023) Vol. 6, Iss. 1, pp. 15-24
Closed Access
Review of daratumumab efficacy in all monoclonal gammopathies and other diseases and our experience with daratumumab, lenalidomide and dexamethasone therapy in 74 patients
Zdeněk Adam, Luděk Pour, Marta Krejčí, et al.
Onkologie (2022) Vol. 16, Iss. Suppl. B, pp. 61-82
Open Access
Page 1

Scroll to top